CYP2C18
| Cytochrome P450, family 2, subfamily C, polypeptide 18 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||
| Symbols | CYP2C18 ; CYP2C; CPCI; CYP2C17; DKFZp686I24235; P450-6B/29C; P450IIC17 | ||||||||||
| External IDs | Template:OMIM5 Template:MGI HomoloGene: 88339 | ||||||||||
| |||||||||||
| RNA expression pattern | |||||||||||
 | |||||||||||
 | |||||||||||
| More reference expression data | |||||||||||
| Orthologs | |||||||||||
| Template:GNF Ortholog box | |||||||||||
| Species | Human | Mouse | |||||||||
| Entrez | n/a | n/a | |||||||||
| Ensembl | n/a | n/a | |||||||||
| UniProt | n/a | n/a | |||||||||
| RefSeq (mRNA) | n/a | n/a | |||||||||
| RefSeq (protein) | n/a | n/a | |||||||||
| Location (UCSC) | n/a | n/a | |||||||||
| PubMed search | n/a | n/a | |||||||||
|
WikiDoc Resources for CYP2C18 |
|
Articles |
|---|
|
Most recent articles on CYP2C18 |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on CYP2C18 at Clinical Trials.gov Clinical Trials on CYP2C18 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on CYP2C18
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating CYP2C18 Risk calculators and risk factors for CYP2C18
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for CYP2C18 |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Cytochrome P450, family 2, subfamily C, polypeptide 18, also known as CYP2C18, is a human gene.[1]
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum but its specific substrate has not yet been determined. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. An additional gene, CYP2C17, was once thought to exist; however, CYP4217 is now considered an artefact based on a chimera of CYP4218 and CYP2C19.[1]
References
Further reading
- Goldstein JA, de Morais SM (1995). "Biochemistry and molecular biology of the human CYP2C subfamily". Pharmacogenetics. 4 (6): 285–99. PMID 7704034.
- Smith G, Stubbins MJ, Harries LW, Wolf CR (1999). "Molecular genetics of the human cytochrome P450 monooxygenase superfamily". Xenobiotica. 28 (12): 1129–65. PMID 9890157.
- Ged C, Beaune P (1993). "Partial sequence and polymerase chain reaction-mediated analysis of expression of the human CYP2C18 gene". Pharmacogenetics. 2 (3): 109–15. PMID 1306110.
- Furuya H, Meyer UA, Gelboin HV, Gonzalez FJ (1991). "Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA". Mol. Pharmacol. 40 (3): 375–82. PMID 1896026.
- Romkes M, Faletto MB, Blaisdell JA; et al. (1991). "Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily". Biochemistry. 30 (13): 3247–55. PMID 2009263.
- Romkes M, Faletto MB, Blaisdell JA; et al. (1993). "Cloning and expression of complementary DNAs for multiple members of the human cytochrome PH50IIC subfamily". Biochemistry. 32 (5): 1390. PMID 8095407.
- Goldstein JA, Faletto MB, Romkes-Sparks M; et al. (1994). "Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans". Biochemistry. 33 (7): 1743–52. PMID 8110777.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. PMID 8125298.
- de Morais SM, Schweikl H, Blaisdell J, Goldstein JA (1993). "Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18". Biochem. Biophys. Res. Commun. 194 (1): 194–201. PMID 8333835.
- Richardson TH, Griffin KJ, Jung F; et al. (1997). "Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C51". Arch. Biochem. Biophys. 338 (2): 157–64. doi:10.1006/abbi.1996.9817. PMID 9028867.
- Zaphiropoulos PG (1997). "Exon skipping and circular RNA formation in transcripts of the human cytochrome P-450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis". Mol. Cell. Biol. 17 (6): 2985–93. PMID 9154796.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. PMID 9373149.
- Macé K, Bowman ED, Vautravers P; et al. (1998). "Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues". Eur. J. Cancer. 34 (6): 914–20. PMID 9797707.
- Klose TS, Blaisdell JA, Goldstein JA (1999). "Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs". J. Biochem. Mol. Toxicol. 13 (6): 289–95. PMID 10487415.
- Finta C, Zaphiropoulos PG (2000). "The human CYP2C locus: a prototype for intergenic and exon repetition splicing events". Genomics. 63 (3): 433–8. doi:10.1006/geno.1999.6063. PMID 10704292.
- Thum T, Borlak J (2000). "Gene expression in distinct regions of the heart". Lancet. 355 (9208): 979–83. PMID 10768437.
- Marill J, Cresteil T, Lanotte M, Chabot GG (2001). "Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites". Mol. Pharmacol. 58 (6): 1341–8. PMID 11093772.
- Zhu-Ge J, Yu YN, Qian YL, Li X (2003). "Establishment of a transgenic cell line stably expressing human cytochrome P450 2C18 and identification of a CYP2C18 clone with exon 5 missing". World J. Gastroenterol. 8 (5): 888–92. PMID 12378636.